HSCT patient and allograft characteristics
Patient no. . | Age, y . | Disease . | Donor . | HLA-match . | PBSC versus BM . | ATG or anti-CD52 . | TCD method . |
---|---|---|---|---|---|---|---|
1 | 31 | MDS | URD | 9/10 C | PBSC | Yes | CD34+ selection |
2 | 46 | AML | Sibling | 10/10 | PBSC | No | CD34+ selection |
3 | 8 | AML | Sibling | 10/10 | BM | No | SBA-E-BM |
4 | 19 | Pre-B ALL | URD | 10/10 | PBSC | Yes | CD34+ selection |
5 | 54 | AML | URD | 9/10 DQ | PBSC | Yes | CD34+ selection |
6 | 5 | AML | URD | 8/10 A,C | BM | Yes | SBA-E-BM |
7 | 55 | CML | Sibling | 10/10 | PBSC | No | CD34+ selection |
8 | 58 | CML | Sibling | 10/10 | PBSC | No | CD34+ selection |
9 | 56 | AML | URD | 9/10 B | PBSC | Yes | CD34+ selection |
10 | 15 | AML | Sibling | 10/10 | PBSC | No | CD34+ selection |
11 | 48 | AML | Sibling | 10/10 | PBSC | No | CD34+ selection |
12 | 29 | AML | Sibling | 10/10 | PBSC | No | CD34+ selection |
13 | 67 | AML | Sibling | 10/10 | PBSC | Yes | CD34+ selection |
14 | 59 | MDS | Sibling | 10/10 | PBSC | Yes | CD34+ selection |
15 | 38 | AML | Sibling | 10/10 | PBSC | Yes | CD34+ selection |
16 | 59 | AML | Sibling | 10/10 | PBSC | Yes | CD34+ selection |
Patient no. . | Age, y . | Disease . | Donor . | HLA-match . | PBSC versus BM . | ATG or anti-CD52 . | TCD method . |
---|---|---|---|---|---|---|---|
1 | 31 | MDS | URD | 9/10 C | PBSC | Yes | CD34+ selection |
2 | 46 | AML | Sibling | 10/10 | PBSC | No | CD34+ selection |
3 | 8 | AML | Sibling | 10/10 | BM | No | SBA-E-BM |
4 | 19 | Pre-B ALL | URD | 10/10 | PBSC | Yes | CD34+ selection |
5 | 54 | AML | URD | 9/10 DQ | PBSC | Yes | CD34+ selection |
6 | 5 | AML | URD | 8/10 A,C | BM | Yes | SBA-E-BM |
7 | 55 | CML | Sibling | 10/10 | PBSC | No | CD34+ selection |
8 | 58 | CML | Sibling | 10/10 | PBSC | No | CD34+ selection |
9 | 56 | AML | URD | 9/10 B | PBSC | Yes | CD34+ selection |
10 | 15 | AML | Sibling | 10/10 | PBSC | No | CD34+ selection |
11 | 48 | AML | Sibling | 10/10 | PBSC | No | CD34+ selection |
12 | 29 | AML | Sibling | 10/10 | PBSC | No | CD34+ selection |
13 | 67 | AML | Sibling | 10/10 | PBSC | Yes | CD34+ selection |
14 | 59 | MDS | Sibling | 10/10 | PBSC | Yes | CD34+ selection |
15 | 38 | AML | Sibling | 10/10 | PBSC | Yes | CD34+ selection |
16 | 59 | AML | Sibling | 10/10 | PBSC | Yes | CD34+ selection |
SBA-E-BM indicates T-cell depletion by bone marrow soybean agglutination with sheep red blood cell (RBC) rosetting; URD, unrelated donor; PBSC, peripheral blood stem cell collection; BM, bone marrow; AML, acute myelogenous leukemia; CML, chronic myelogenous leukemia; MDS, myelodysplastic syndrome; and ALL, acute lymphoblastic leukemia.